Lantheus Holdings, Inc.

LNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Oct 22, 2026 8-K
8-K Oct 14, 2026 8-K
DEFA14A Oct 2, 2026 DEFA14A
8-K Oct 2, 2026 8-K
SCHEDULE 13D/A Sep 23, 2026
DEFA14A Sep 21, 2026 DEFA14A
8-K Sep 21, 2026 8-K
DEFA14A Sep 17, 2026 DEFA14A
4 Sep 8, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
DEFM14A Sep 8, 2026 DEFM14A
4 Sep 4, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
SCHEDULE 13D/A Sep 4, 2026
SCHEDULE 13G Sep 4, 2026
SCHEDULE 13D Sep 4, 2026
4 Sep 3, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 2, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Sep 2, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
S-8 Sep 2, 2026 S-8
PREM14A Aug 26, 2026 PREM14A
4 Aug 19, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
4 Aug 19, 2026 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
DEFA14A Aug 13, 2026 DEFA14A
SCHEDULE 13G/A Aug 13, 2026
10-Q Aug 6, 2026 10-Q
8-K Aug 6, 2026 8-K
← Newer Page 1 of 45 · 1116 filings Older →